Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
5
×
fda
5
×
life sciences
national blog main
clinical trials
national top stories
biotech
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alexion pharmaceuticals
amyotrophic lateral sclerosis (als)
boston
deals
eli lilly
gene therapy
gilead sciences
glaxosmithkline
sanofi
ucb
abbvie
What
pharma
5
×
drug
bio
disease
medicines
pharmaceuticals
roundup
abbvie’s
administration
ahead
alternative
angry
anti
autoimmune
benefited
biofourmis
biopharma
bucks
cancer
candidate
caught
causing
celebrate
chance
congress
congressional
corner
crispr
day
days
deal
despite
dicerna
executives
expensive
eye
fear
feud
forward
gene
Language
unset
Current search:
fda
×
" boston top stories "
×
pharma
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More